Pasquale De Cata
Dirigente medico

Richiedi appuntamento
Specializzazione
  • Diabetologia
  • Medicina interna
Contatti
  • 0382.592697
  • [javascript protected email address]

Segagni D, Sacchi L, Dagliati A, Tibollo V, Leporati P, De Cata P, Chiovato L, Bellazzi R. Improving Clinical Decisions on T2DM Patients Integrating Clinical, Administrative and Environmental Data.Stud Health Technol Inform. 2015; 216:682-686.

R. Dionisio,A.Giardini, P.De Cata, B.Pirali,S.Rossi,E.M Negri, P.Ferrari and P.Preti, Diabetes Management in End of Life: A Preliminary report Stemming From Clinical Experience. American Journal of Hospice & Palliative Medicine 2015; 32:588-593

Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti AM, De Cata P, Salvetti M, Chiovato L, Castellano M. Metformin-induced thyrotropin suppression is not associated with cardiac effects. Hormones (Athens) 2014; 13:252-258

Rotondi M, Cappelli C, Magri F, Botta R, Dionisio R, Iacobello C, De Cata P, Nappi RE, Castellano M, Chiovato L. Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.Clin Endocrinol (Oxf) 2011; 75:378-381

M.T Tenconi , G.Devoti, M.Comelli, M.Pinon, A. Capocchiano, G.Pretti, L.Bobba, A.Buratti, L. Cacciabue, P. De Cata, M.Lorena, E.Lovati, C.Mezzogori, A.Rea, M. Rebagliati, P. Romagnoli, M.Romani, B.Solerte, T.Tognin, A.Vailati. Major childhood infectious  diseases and other determinants associated with type 1 diabetes: A case –control study Acta Diabetologica 2007; 44 (1) : 14-19

Larizza C, Bellazzi R, Stefanelli M,  Ferrari P, De Cata P, Gazzaruso C, Fratino P, D'Annunzio G, Hernando E, Gomez EJ. The M2DM Project-the experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients.Methods Inf Med. 2006; 45:79-84.

Bellazzi R, Arcelloni M, Ferrari P, De Cata P, Hernando ME, García A, Gazzaruso C, Gómez EJ, Larizza C, Fratino P, Stefanelli M. Management of patients with diabetes through information technology: tools for monitoring and control of the patients' metabolic behavior. Diabetes Technol Ther. 2004; 6:567-578.

Bellazzi R, Arcelloni M, Bensa G, Blankenfeld H, Brugués E, Carson E, Cobelli C, Cramp D, D'Annunzio G, De Cata P, De Leiva A, Deutsch T, Fratino P, Gazzaruso C, Garcìa A, Gergely T, Gómez E, Harvey F, Ferrari P, Hernando E, Boulos MK, Larizza C, Ludekke H, Maran A, Nucci G, Pennati C, Ramat S, Roudsari A, Rigla M, Stefanelli M. Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients.Diabetes Technol Ther. 2003; 5:621-629.

Gazzaruso C, Giordanetti S, De Cata P, Poggi G, Fratino P. Early diagnosis of primary biliary cirrhosis in type 1 diabetes: the possible role of eosinophilia. Diabetes Care. 2003; 26:2963-2944

Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Dalla Paola L, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225-232.

Presta servizio in queste sedi

Profili simili


GH4T12Fv7resHnpU